Whoop Women's Health
A 54-biomarker women's health panel inspired by the WHOOP Women's Health Panel — fertility, cycle and thyroid hormones plus a complete metabolic and nutrient base.
According to the NVKC, anti-Müllerian hormone (AMH) already plays a role before birth in forming the reproductive organs, and in women after puberty in the growth and maturation of the follicles, the egg sacs. The support cells of those follicles make it, and the NVKC therefore calls the amount in the blood a measure of the follicle supply.
According to the NVKC, AMH in women falls at a constant rate from a certain age. The international guideline on polycystic ovary syndrome (PCOS) adds that AMH is lower with a higher BMI (body mass index, weight relative to height) in the general population. In PCOS itself, AMH is strongly raised instead, according to the NVKC. Whether someone's AMH turns out low or high only shows in a blood test.
Unilabs uses 0.58 to 8.13 µg/l for women aged 30 up to and including 34, Star-SHL 0.71 to 7.59 µg/l for the same age group. According to the NVKC, the measured amount of AMH depends on the measurement method, and limits can therefore differ between laboratories.
Doctor's Assessment Included
AMH is a measure of the follicle supply in the ovaries, and in women the value falls with age. Star-SHL, Unilabs, Certe and Diagnostiek voor U use limits per age for women.
See the value that applies to you:
Choose male or female — this range differs by sex.
Enter your age — this range changes with age.
This range also depends on context such as cycle phase or sample material; the highlighted rows apply to your group.
| Sex | Age | Reference range (ug/l) | Relative scale |
|---|---|---|---|
| Male | 1,43–11,6 ug/l |
1,43
11,6
|
|
| Female | · 20–24 years | 1,52–9,95 ug/l |
1,52
9,95
|
| Female | · 25–29 years | 1,2–9,05 ug/l |
1,2
9,05
|
| Female | · 30–34 years | 0,71–7,59 ug/l |
0,71
7,59
|
| Female | · 35–39 years | 0,41–6,96 ug/l |
0,41
6,96
|
| Female | · 40–44 years | 0,06–4,44 ug/l |
0,06
4,44
|
| Female | · 45–50 years | < 1,79 ug/l |
1,79
|
Package-insert value: 5th-95th percentile per age group (n = 148 men; 150 at 20-24 years; 150 at 25-29; 138 at 30-34; 138 at 35-39; 142 at 40-44; 169 at 45-50 years). AMH does not depend on the menstrual cycle and can be measured on any cycle day. The reference group did not use hormonal contraception: combined contraception lowers AMH, so a value taken while on the pill can come out low. The lower limit of 0.010 at 45-50 years is the detection limit of the test, not a measured percentile. A hormone reference value is assay-specific; these values apply to the Roche Elecsys method.
Source: Roche Diagnostics Reference population: Roche reference cohort (Elecsys AMH Plus package insert)
Reference ranges may vary between laboratories. When you order a test, a BIG-registered doctor assesses your personal results in context. For treatment decisions, discuss your results with your GP.
Check your own value| Laboratory | Group | Reference value (ug/l) | Relative scale |
|---|---|---|---|
| Star-shl | · Female · 20–24 years | 1.52–9.95 µg/l |
1.52 9.95
|
| Star-shl | · Female · 25–29 years | 1.20–9.05 µg/l |
1.2 9.05
|
| Star-shl | · Female · 30–34 years | 0.71–7.59 µg/l |
0.71 7.59
|
| Star-shl | · Female · 35–39 years | 0.41–6.96 µg/l |
0.41 6.96
|
| Star-shl | · Female · 40–44 years | 0.06–4.44 µg/l |
0.06 4.44
|
| Star-shl | · Female · 45–50 years | 0.01–1.79 µg/l |
0.01 1.79
|
| Star-shl | · Male · 18–50 years | 1.43–11.60 µg/l |
1.43 11.6
|
| Unilabs | · Female · 20–25 years | 1.22–11.70 µg/l |
1.22 11.7
|
| Unilabs | · Female · 25–30 years | 0.89–9.85 µg/l |
0.89 9.85
|
| Unilabs | · Female · 30–35 years | 0.58–8.13 µg/l |
0.58 8.13
|
| Unilabs | · Female · 35–40 years | 0.15–7.49 µg/l |
0.15 7.49
|
| Unilabs | · Female · 40–45 years | 0.03–5.47 µg/l |
0.03 5.47
|
| Unilabs | · Female · 45–50 years | 0.01–2.71 µg/l |
0.01 2.71
|
| Unilabs | · Female · 50 years and older | 0.00–0.05 µg/l |
0 0.05
|
| Unilabs | · Male · 18 years and older | 0.77–14.50 µg/l |
0.77 14.5
|
| Certe | · Female · 20–25 years | 1.22–11.70 ug/L |
1.22 11.7
|
| Certe | · Female · 25–30 years | 0.89–9.85 ug/L |
0.89 9.85
|
| Certe | · Female · 30–35 years | 0.576–8.130 ug/L |
0.576 8.13
|
| Certe | · Female · 35–40 years | 0.147–7.490 ug/L |
0.147 7.49
|
| Certe | · Female · 40–45 years | 0.027–5.470 ug/L |
0.027 5.47
|
| Certe | · Female · 45–50 years | 0.01–2.71 ug/L |
0.01 2.71
|
| Certe | · Male · 19 years and older | 0.77–14.50 ug/L |
0.77 14.5
|
| Diagnostiek voor U | · Female · 19–20 years | 1.22–5.97 µg/L |
1.22 5.97
|
| Diagnostiek voor U | · Female · 21 years | 1.30–6.12 µg/L |
1.3 6.12
|
| Diagnostiek voor U | · Female · 22 years | 1.35–6.28 µg/L |
1.35 6.28
|
| Diagnostiek voor U | · Female · 23 years | 1.41–6.45 µg/L |
1.41 6.45
|
| Diagnostiek voor U | · Female · 24 years | 1.36–6.62 µg/L |
1.36 6.62
|
| Diagnostiek voor U | · Female · 25 years | 1.32–6.79 µg/L |
1.32 6.79
|
| Diagnostiek voor U | · Female · 26 years | 1.26–6.88 µg/L |
1.26 6.88
|
| Diagnostiek voor U | · Female · 27 years | 1.20–6.83 µg/L |
1.2 6.83
|
| Diagnostiek voor U | · Female · 28 years | 1.15–6.74 µg/L |
1.15 6.74
|
| Diagnostiek voor U | · Female · 29 years | 1.11–6.52 µg/L |
1.11 6.52
|
| Diagnostiek voor U | · Female · 30 years | 1.07–6.32 µg/L |
1.07 6.32
|
| Diagnostiek voor U | · Female · 31 years | 0.96–5.97 µg/L |
0.96 5.97
|
| Diagnostiek voor U | · Female · 32 years | 0.87–5.63 µg/L |
0.87 5.63
|
| Diagnostiek voor U | · Female · 33 years | 0.79–5.26 µg/L |
0.79 5.26
|
| Diagnostiek voor U | · Female · 34 years | 0.69–4.87 µg/L |
0.69 4.87
|
| Diagnostiek voor U | · Female · 35 years | 0.63–4.54 µg/L |
0.63 4.54
|
| Diagnostiek voor U | · Female · 36 years | 0.55–4.19 µg/L |
0.55 4.19
|
| Diagnostiek voor U | · Female · 37 years | 0.47–3.85 µg/L |
0.47 3.85
|
| Diagnostiek voor U | · Female · 38 years | 0.39–3.52 µg/L |
0.39 3.52
|
| Diagnostiek voor U | · Female · 39 years | 0.31–3.15 µg/L |
0.31 3.15
|
| Diagnostiek voor U | · Female · 40 years | 0.24–2.83 µg/L |
0.24 2.83
|
| Diagnostiek voor U | · Female · 41 years | 0.20–2.54 µg/L |
0.2 2.54
|
| Diagnostiek voor U | · Female · 42 years | 0.14–2.29 µg/L |
0.14 2.29
|
| Diagnostiek voor U | · Female · 43 years | 0.09–2.05 µg/L |
0.09 2.05
|
| Diagnostiek voor U | · Female · 44 years | 0.07–1.80 µg/L |
0.07 1.8
|
| Diagnostiek voor U | · Female · 45 years | 0.05–1.55 µg/L |
0.05 1.55
|
| Diagnostiek voor U | · Female · 46 years | 0.04–1.44 µg/L |
0.04 1.44
|
| Diagnostiek voor U | · Female · 47 years | 0.03–1.32 µg/L |
0.03 1.32
|
| Diagnostiek voor U | · Female · 48 years | 0.02–1.21 µg/L |
0.02 1.21
|
| Diagnostiek voor U | · Female · 49 years | 0.01–1.11 µg/L |
0.01 1.11
|
| Diagnostiek voor U | · Female · 50 years · a limit, not a range | < 1.01 µg/L |
1.01
|
| Diagnostiek voor U | · Female · 52 years and older · a limit, not a range · after menopause | < 0.1 µg/L |
0.1
|
| Diagnostiek voor U | · Male · 15 years and older | 2.26–16.86 µg/L |
2.26 16.86
|
Source: Star-shl
Source: Unilabs
Source: Certe
Source: Diagnostiek voor U
Each value as the laboratory itself publishes it, retrieved in 2026.
In micrograms per litre (µg/l), the result shows how much anti-Müllerian hormone the blood contains. Star-SHL outsources the test to the Algemeen Medisch Laboratorium, and according to Unilabs the test goes to UMC Utrecht.
The international PCOS guideline asks laboratories that measure AMH in women to use limits that fit their own population and measurement method. Laboratories also print limits for adult men: Star-SHL 1.43 to 11.60 µg/l from 18 to 50, Unilabs 0.77 to 14.5 µg/l from 18.
An AMH value only gains meaning next to the limit for one's own age and one's own laboratory, because in women AMH falls with age and according to the NVKC the measured amount depends on the measurement method. According to the international PCOS guideline, AMH is also lower with a higher BMI (body mass index, weight relative to height) in the general population, and it may vary across the menstrual cycle.
In a large study, AMH in users of hormonal contraception was, compared with women without contraception, on average about 24 percent lower with the combined pill, 22 percent with the ring and 23 percent with an implant.
Nothing special is needed for these tests.
Your cycle does not matter here
Good to knowThis value barely changes, including through a menstrual cycle. Any day works.
Before IVF (in vitro fertilisation) treatment, the European guideline recommends AMH or an ultrasound count of the small follicles to predict the response to stimulation. AMH is also measured when polycystic ovary syndrome (PCOS) is investigated. The Dutch guideline advises against an AMH test in the first fertility work-up of a couple who have not yet conceived.
The international PCOS guideline notes that current or recent pill use may suppress AMH.
A low AMH is a value below the lower limit a laboratory uses for the age group, and that lower limit differs between laboratories. Star-SHL sets the lower limit for women aged 40 to 44 at 0.06 µg/l, Unilabs at 0.03 µg/l. An AMH of 0.05 µg/l therefore falls below the limit at Star-SHL and within it at Unilabs.
The form of hormonal contraception also counts with a low AMH. A large study found on average about 7 percent less AMH with a hormonal coil and about 15 percent less with the mini-pill, a pill without oestrogen, than without contraception. With a copper coil, which releases no hormone, the difference was not significant.
Whether an AMH is high depends on age, because the upper limit also differs per age group. According to the international guideline on polycystic ovary syndrome (PCOS), AMH generally peaks between the ages of 20 and 25 in the general population. Star-SHL uses an upper limit of 9.95 µg/l for women aged 20 to 24 and 4.44 µg/l for women aged 40 to 44. At Star-SHL, an AMH of 6 µg/l falls within the limit for the younger of those two groups and above the one for the older.
The international guideline recommends against making the PCOS diagnosis with AMH as the single test.
Age
The amount of AMH falls in women from a certain age, while FSH rises.
Premature ovarian insufficiency
In premature ovarian insufficiency, in which, according to the European guideline, ovarian function stops before age 40, AMH can be low. According to the European guideline, an AMH test may help confirm that diagnosis when the FSH result is inconclusive, but it is not the primary test.
Hormonal contraception
Users of hormonal contraception had on average about a quarter lower AMH values in one study than women not using hormonal contraception; that effect proved reversible.
Surgery on an endometriosis cyst
After removal of an endometriosis cyst, AMH fell on average in a review of studies, which suggests a possible negative effect on the egg supply, although the studies differed widely.
Chemotherapy for breast cancer
In women of reproductive age with breast cancer, AMH fell to undetectable levels during chemotherapy in most and generally stayed very low afterwards in most.
Polycystic ovary syndrome (PCOS)
In women with PCOS, AMH is strongly raised according to the NVKC, and according to the NVKC the result must be combined with a transvaginal ultrasound, an internal scan through the vagina, for the diagnosis.
Have a repeat AMH measurement done by the same laboratory, because according to the NVKC the measurement method affects the outcome.
Note whether you use hormonal contraception, and which form, because in research AMH was lower in users of the combined pill, the ring and an implant.
AMH limits can differ between laboratories, according to the NVKC because the measured amount of AMH depends on the measurement method. Star-SHL, for example, uses 0.41 to 6.96 µg/l for women in the age group 35 up to and including 39, and Unilabs 0.15 to 7.49 µg/l.
Yes, according to the international PCOS guideline, AMH is lower in people with a higher BMI (body mass index, weight relative to height) in the general population. That link holds for the population as a whole and gives no limit for one person.
Yes, men also have AMH in the blood, and laboratories print limits for it: Star-SHL 1.43 to 11.60 µg/l from 18 to 50 and Unilabs 0.77 to 14.5 µg/l from 18.
This marker is included in the following test panels.
A 54-biomarker women's health panel inspired by the WHOOP Women's Health Panel — fertility, cycle and thyroid hormones plus a complete metabolic and nutrient base.
Medical reviewer
Dr. Naimi oversees the medical standards behind our content and assessments.
Medical policyDoctor's Assessment Included
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
AMH (Anti-Müllerian Hormone)
€54,-
We use cookies to analyze site usage and measure ad effectiveness. Privacy Policy